Shopping Cart
- Remove All
- Your shopping cart is currently empty
BMS-593214 is an active site-directed factor (F) VIIa inhibitor that exhibits antithrombotic and antihaemostatic properties. It acts as a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of FVIIa-activated substrate FX. Additionally, BMS-593214 effectively prevents electroinduced carotid artery thrombosis (AT) and wire-induced vena cava thrombosis (VT).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $297 | In Stock | |
5 mg | $745 | In Stock | |
10 mg | $1,120 | In Stock | |
25 mg | $1,670 | In Stock | |
50 mg | $2,180 | In Stock | |
100 mg | $2,800 | In Stock |
Description | BMS-593214 is an active site-directed factor (F) VIIa inhibitor that exhibits antithrombotic and antihaemostatic properties. It acts as a direct competitive inhibitor of human FVIIa and a non-competitive inhibitor of FVIIa-activated substrate FX. Additionally, BMS-593214 effectively prevents electroinduced carotid artery thrombosis (AT) and wire-induced vena cava thrombosis (VT). |
Alias | BMS593214, BMS 593214 |
Molecular Weight | 505.56 |
Formula | C31H27N3O4 |
Cas No. | 1004551-40-9 |
Smiles | C(=N)(N)C=1C=C2[C@@]3([C@]([C@@H](NC2=CC1)C4=C(C=C(O)C(OC)=C4)C5=CC=C(C(O)=O)C=C5)(CC=6C3=CC=CC6)[H])[H] |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (158.24 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.